Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 6 - 8 JANUARY 2021 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 90/2020. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information: Martin Badsted, CFO, tel.: +45 3315 0451

Assemblin acquires additional ventilation in Norway

Through the acquisition of the ventilation specialist Nor-Klima T. Svendsen AS (”Nor-Klima”) Assemblin strengthens its position within ventilation in Drammen, Norway.Nor-Klima was founded in 1992 and is a ventilation company with operations in the Drammen area (west of Oslo) with annual sales of approximately SEK 33 million. “Two years ago we started our ventilation operations in Norway and have since grown organically, delivering more than ten projects with high customer satisfaction and strong results. Today, we have a stable ventilation platform and, with this acquisition, we gain

Stora Enso’s pellet packaging wins global Worldstar design award

STORA ENSO OYJ PRESS RELEASE 8 January 2021 at 10.00 EETStora Enso’s design for eco-friendly pellet packaging was awarded with a prestigious Worldstar award. The renewable and recyclable packaging is designed for heavy use in transporting and warehousing of wood pellets for heating. The awarded packaging is a sustainable alternative to the standard plastic bag used in the pellet industry. In the packaging design work, special attention was paid to usability, recyclability and visual appearance. The 12 kg pellet box, which replaces a plastic bag, is easy to bring home from the store

East Capital Group selects Acty to streamline its active ownership efforts

Acty, a platform for managing active ownership, has been selected by East Capital Group as the platform to manage and monitor its engagement activities globally.Acty is a tool that facilitates investors’ engagement with portfolio holdings and other stakeholders, by structuring data and processes, automating reports and allowing collaboration with other investors. Acty’s aim is to set a global standard for successful active ownership processes. As a responsible owner, East Capital Group has been engaging with portfolio companies since 1997; first in Russia and Eastern Europe, then

ExpreS2ion announces submission of the COUGH-1 clinical trial application by the Prevent-nCoV consortium and Bavarian Nordic to review ABNCoV2

Hørsholm, Denmark, January 8, 2021 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that the clinical trial application (CTA) for a clinical Phase I/II study for the ABNCoV2 capsid virus-like particle (cVLP) based COVID-19 vaccine has been submitted to the Central Committee on Research Involving Human Subjects (CCMO) in the Netherlands. The CTA is expected to be approved under a COVID-19 fast-track review procedure. The CTA submission is in line with the plans to present initial clinical Phase I/IIa results in Q1 2021.With the submission of

Drug substance for the ALZ-101 vaccine is now produced – meets the requirements of the upcoming clinical Phase 1b study

Alzinova AB has secured materials for the clinical Phase 1b study through the manufacturing of the drug substance for the oligomer-specific vaccine ALZ-101. The high-purity material meets the quality requirements of the clinical trial. The clinical trial with ALZ-101 on Alzheimer's disease patients is expected to start during the second quarter of 2021.“We are very pleased that the drug substance for the upcoming clinical Phase 1b study with ALZ-101 is now manufactured. For us, this is an important milestone, showing that the drug substance for the ALZ-101 vaccine can be manufactured to a

Skanska invests about SEK 580M in rental apartments in Barkarbystaden, Sweden

Skanska is investing about SEK 580 million in the multifamily project Parkkvarteret with 220 rental apartments in Barkarbystaden, Järfälla, Sweden. The project is developed by Skanska Rental Housing and the construction contract is worth approximately SEK 370 million, which is included in the order bookings for Skanska Sweden for the fourth quarter 2020.The project is located next to the new Veddesta bridge with direct connection to the commuter train station, future metro station and service as well as park environments. Here, Skanska develops and builds an apartment building with 220

myFC participates in concept study for small vehicles with the Swedish Energy Agency

Micro fuel cell company myFC has been selected to participate in a concept study for the development of small, environmentally friendly, cost and energy efficient vehicles. The study is funded by the Swedish Energy Agency, led by research institute RISE, with the overall objective to reduce emissions and strengthen the competitiveness of the Swedish automotive industry.The project will be conducted during the spring of 2021 under the framework of the initiative Strategic Vehicle Research and Innovation (FFI), and is particularly focused on smaller vehicles such as pod taxis. The aim is to

Heimstaden Bostad successfully prices EUR 500 million senior unsecured bond

Heimstaden Bostad AB yesterday successfully priced a EUR 500 million senior unsecured bond under its EMTN programme. The bond has maturity of two years with a call option at par after approx. one year and carries a floating rate of 3 months EURIBOR plus 55 bps. The issuance was completed through a club deal with European money market funds. The proceeds will be used for general corporate purposes and repayment of secured bank financing. An application will be made for the bond to be listed on Euronext Dublin. The final listing particulars, once published, will be made available on

Hunter Group ASA - Key information relating to the proposed dividend

Oslo, 8 January 2021   The board of directors of Hunter Group ASA has proposed a cash dividend distribution of NOK 1.00 per share (excluding treasury shares). The distribution will be conducted as a reduction of the Company’s share premium and could hence have favourable tax implications for some shareholders.  Dividend amount: NOK 1.00 per share Declared currency: NOK Last day including right: 1 February 2021 Ex-date: 2 February 2021 Record date: 3 February 2021 Payment date: 8 February 2021 Date of approval: 1 February 2021   Contact: Erik A.S.

Skanska renovates Pennsylvania Station Long Island Rail Road Concourse in New York, USA, for USD 392M, about SEK 3.2 billion

Skanska has signed a contract with Penn District Station Developer LLC to renovate Pennsylvania Station’s Long Island Rail Road (LIRR) concourse in New York, New York, USA. The contract is worth USD 392M, about SEK 3.2 billion, and will be included in the US order bookings for the fourth quarter of 2020.The contract includes the design and construction of the widening of the LIRR 33rd Street train hall corridor, including raised ceiling heights, upgraded lighting and wayfinding, digital information screens, and mechanical and electrical work along with new architectural finishes and station

Hunter Group ASA - Notice of Extraordinary General Meeting

Oslo, 8 January 2021 The board of directors of Hunter Group ASA hereby calls for an extraordinary general meeting to be held on 1 February 2021 at 09:00 CET at the Company’s offices at Dronningen 1, 0287 Oslo. The notice of the general meeting including the notice of attendance and proxy form is attached to this notice. Due to restrictions caused by Covid-19, shareholders are encouraged to exercise their shareholder rights without attending the general meeting in person. Voting will be available through proxy, according to the instructions provided in this notice, or electronically

Brighter’s diabetes management devices Actiste® and Actiste® Mini receives market approval in Thailand

Brighter AB (publ) is proud to announce that the Actiste® device and the newly developed Actiste® Mini device have received market approval from the Thai FDA, which is a prerequisite to start importing and marketing the products. A cellular transmission approval process, which is a requirement for activation and use of the products, is under way. Further information about Brighter’s commercial plan and strategy for Thailand will follow during the spring. “We are very pleased to have reached another significant milestone in the commercialization of the Actiste portfolio. This time in

Attana will participate at Biotech Showcase™ 2021

Attana will participate at one of the largest biotech conferences in the world – Biotech Showcase™ 2021. Attending the conference are global investors and over a thousand potential customers and strategic partners.The conference, this year in a digital form, takes place on January 11 to January 15. Attana will broadcast a 30-minute presentation and then participate in digital one-on-one meetings. Attana will mainly focus on connecting with new customers but also welcome discussions with potential strategic partners and investors. The presentation will also be published on Attana’s website

ABS and Keppel Continue to Demonstrate Digital Leadership with World’s First Smart Bunkering Vessel

Smart Notations and Smart Technologies Integrated into Industry’s First LNG Bunkering Vessel(SINGAPORE) ABS and Keppel Offshore & Marine are continuing their pioneering application of digital technologies by integrating Smart functions into the world’s first smart LNG bunkering vessel – FueLNG Bellina, equipped with Keppel O&M’s proprietary AssetCare Digital Solution. ABS was selected by FueLNG Pte Ltd, to class the vessel, which will feature notations for Smart Infrastructure (Smart INF) and Crew Assistance and Augmentation (Smart CAA). Obtaining these notations form an integral part of

#21-6 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#21-5 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

EQT and Verdane announce intention to merge FocusVision and Confirmit

· EQT and Verdane to merge FocusVision and Confirmit to create a leader in the Market Research, Customer and Employee Experience industries  · The combined company will provide a one-stop-shop of complementary software solutions and offer greater benefits to existing and new customers  · EQT and Verdane are committed to invest in the combined company to support accelerated growth in North America and Europe EQT and Verdane are pleased to announce the merger of their respective portfolio companies FocusVision, majority owned by EQT Mid Market US, and Confirmit. The combined

Correction to Nurminen Logistics Plc’s Stock Exchange Release published on 5 January 2021 related to the received notification from Ilmarinen Mutual Pension Insurance Company

Nurminen Logistics Plc                        Stock Exchange Release 7 January 2021 at 4.30 pm   The Stock Exchange Release published by Nurminen Logistics Plc on 5 January 2021 incorrectly stated, based on the received notification form of Ilmarinen Mutual Pension Insurance Company, that the total holding of Ilmarinen Mutual Pension Insurance Company in the Company is 11,83 percent (8 780 000 shares and votes), and 5,55 percent (4 120 879 shares and votes through financial instruments). In total 17,38 percent.   Nurminen Logistics Plc (Nasdaq Helsinki: NLG1V) (“Nurminen Logistics”,

Proposals of Atria Plc's nomination board for the annual general meeting

Atria Plc  Company Announcement, 7 January 2021, at 4.00 pmProposals of Atria Plc's nomination board for the annual general meetingThe Nomination Board elected Jyrki Halonen as Chairman from among its members.The Nomination Board's proposal concerning the number of the members of the Board of DirectorsThe Nomination Board has decided to propose to the General Meeting that a total of eight members be elected to the Board of Directors.The Nomination Board's proposal concerning the members of the Board of DirectorsThe Nomination Board has decided to propose to the General Meeting

Renewable Power Capital marks first investment with commitment to acquire a portfolio of Nordic onshore wind projects from OX2

· Renewable Power Capital has committed to acquire projects in Finland with capacity totalling 171 MW · OX2 is constructing the wind farms under a tailored EPC contract and will, once commissioned, be responsible for the technical and commercial management of the wind farms.London, U.K. (January 07, 2021) –  Renewable Power Capital (“RPC”), the renewable energy investment platform backed by Canada Pension Plan Investment Board (CPP Investments), has made its first investment by committing to the acquisition of a 100% ownership interest in a 171MW portfolio of onshore wind projects from

First patient in treatment in RhoVac's clinical phase IIb study in United Kingdom

RhoVac AB ("RhoVac") announces today, on January 7[th], 2021, that the first patient in United Kingdom is enrolled in the company's clinical phase IIb study in prostate cancer, a study named RhoVac-002 ("BRaVac").The first patient in United Kingdom is enrolled in the clinical study, called BRaVac. This clinical trial phase IIb-study is a randomized, placebo controlled and double-blind study, with the primary objective of evaluating if treatment with the drug candidate RV001 can prevent or limit the development of advanced prostate cancer after curative intent treatment. The clinical phase

Etrion Corporation redeems EUR 40 million of outstanding Corporate Bonds ISIN N00010823958 – Etrion Corporation Senior Secured Bond Issue 2018/2021

January 7, 2021, Geneva, Switzerland – Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), a solar independent power producer, announces that it has today successfully redeemed the EUR 40 million of outstanding Corporate Bonds, in full and at a redemption price of 100.725% of the face value plus accrued and unpaid interest. About Etrion Etrion Corporation is an independent power producer that develops, builds, owns and operates utility-scale solar power generation plants. The Company owns and operates 57 MW of solar capacity and owns the 45 MW Niigata project under

There are no items matching the current filter
There are no more items matching the current filter
Back to top